Pictet Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.06M | Buy |
969,041
+356,717
| +58% | +$3.33M | 0.01% | 670 |
|
|
2025
Q1 | $4.8M | Buy |
612,324
+585,882
| +2,216% | +$4.6M | 0.01% | 807 |
|
|
2024
Q4 | $199K | Buy |
26,442
+6,840
| +35% | +$51.4K | ﹤0.01% | 1859 |
|
|
2024
Q3 | $149K | Hold |
19,602
| – | – | ﹤0.01% | 1894 |
|
|
2024
Q2 | $121K | Hold |
19,602
| – | – | ﹤0.01% | 1862 |
|
|
2024
Q1 | $99.6K | Hold |
19,602
| – | – | ﹤0.01% | 1882 |
|
|
2023
Q4 | $117K | Sell |
19,602
-4,172,698
| -100% | -$25M | ﹤0.01% | 1855 |
|
|
2023
Q3 | $29.7M | Buy |
+4,192,300
| New | +$29.7M | 0.04% | 368 |
|